Amit Sachdev - Net Worth and Insider Trading
Amit Sachdev Net Worth
The estimated net worth of Amit Sachdev is at least $31 Million dollars as of 2024-11-13. Amit Sachdev is the EVP Chief Patient & Ext Af Off of Vertex Pharmaceuticals Inc and owns about 62,772 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $31 Million. Details can be seen in Amit Sachdev's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amit Sachdev has not made any transactions after 2024-02-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amit Sachdev
Amit Sachdev Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amit Sachdev owns 2 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , and Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of Amit Sachdev’s form 4 insider trades.
Insider Ownership Summary of Amit Sachdev
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2024-02-26 | SVP & Public Policy,Gov Affairs |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-11 | director |
Amit Sachdev Latest Holdings Summary
Amit Sachdev currently owns a total of 1 stock. Amit Sachdev owns 62,772 shares of Vertex Pharmaceuticals Inc (VRTX) as of February 26, 2024, with a value of $31 Million.
Latest Holdings of Amit Sachdev
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2024-02-26 | 62,772 | 490.00 | 30,758,280 |
Holding Weightings of Amit Sachdev
Amit Sachdev Form 4 Trading Tracker
According to the SEC Form 4 filings, Amit Sachdev has made a total of 28 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 28 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 3,004 shares on February 26, 2024, which brought Amit Sachdev around $1 Million.
Insider Trading History of Amit Sachdev
- 1
Amit Sachdev Trading Performance
Amit Sachdev Ownership Network
Ownership Network List of Amit Sachdev
Ownership Network Relation of Amit Sachdev
Amit Sachdev Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Amit Sachdev is the SVP & Public Policy,Gov Affairs of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Amit Sachdev made 6 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 23,737. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 16,533 shares made by Ourania Tatsis , and a net sale of 77,232 shares made by Reshma Kewalramani .
In summary, during the past 3 months, insiders sold 5,429 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 5,429 shares. During the past 18 months, 340,041 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,041 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Amit Sachdev Mailing Address
Above is the net worth, insider trading, and ownership report for Amit Sachdev. You might contact Amit Sachdev via mailing address: C/o Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
